.custom-subheader { font-family: Roboto, "Helvetica Neue", Helvetica, Arial, sans-serif; font-size: 17px; font-weight: 600; line-height: 1.5em; margin-top: 1.5em; margin-bottom: 1em; }
Skip to main content
Displaying 94 of 2939 articles.
New study demonstrates how high-affinity B cells "bank" their best traits instead of rolling the dice and risking deleterious mutations, with implications for better vaccine design.

A collaboration between Rockefeller, MSK, and Weill Cornell answers a longstanding mystery about the basic biology of the hepatitis B virus, while also proposing a novel therapy.

A treatment that appears effective in cancers such as myelofibrosis consistently fails in breast cancer clinical trials. A new study explains why.

New findings describe how the enzyme CST is recruited to the end of the telomere, where it maintains telomere length with the help of subtle chemical changes made to the protein POT1.

The end replication problem dictates that telomeres shrink unless telomerase intervenes. But the problem is actually twice as complicated, with telomerase providing only part of the solution.

Telomerase could run amok, deleteriously capping damaged DNA, were it not for a first responder to DNA damage.

Marraffini is honored for his pioneering research on the study of CRISPR-Cas systems.

Birsoy is honored for groundbreaking research uncovering metabolic weaknesses of diseased cells, such as cancer, while shedding light on debilitating mitochondrial diseases and rare genetic disorders.

Researchers have long disagreed over whether ??T cells in the gut promote or discourage tumor growth, but new evidence suggests they have the capacity to do both.

She receives the honor for elucidating mechanisms of telomere protection and genome maintenance.
View
View